GlobeNewswire - Prospectus, Announcement Of Prospectus

Prospekt Februar 2021

2021-02-24T13:12:23Z

Investeringsforeningen Gudme Raaschou har offentliggjort opdateret prospekt for foreningen.

Prospekt Februar 2021

2021-02-24T13:04:35Z

Kapitalforeningen L?n & Spar MixInvest har offentliggjort opdateret prospekt for foreningen.

Prospekt Februar 2021

2021-02-24T12:53:01Z

Investeringsforeningen L?n & Spar Invest har offentliggjort opdateret prospekt for foreningen.

Endelige vilk?r for SDRO udstedt af Realkredit Danmark A/S

2021-02-24T08:11:55Z

Realkredit Danmark ?bner ny obligation.

Den nye obligation optages til notering p? NASDAQ Copenhagen.

Den nye obligation er omfattet af "Basisprospekt for realkreditobligationer og s?rligt d?kkede realkreditobligationer udstedt af Realkredit Danmark A/S". ?

Basisprospektet er tilg?ngeligt p? Realkredit Danmarks internetside p? www.rd.dk/Investor.

De endelige vilk?r offentligg?res hermed.

Prospekt Februar 2021

2021-02-23T18:00:00Z

Investeringsforeningen Fundamental Invest har offentliggjort opdateret prospekt for foreningen.

Prospekt Februar 2021

2021-02-23T14:16:50Z

Investeringsforeningen Selected Investments har offentliggjort opdateret prospekt for foreningen.

Opdatering af prospektet og CI-dokumenter i Handelsinvest

2021-02-23T13:54:59Z

Investeringsforeningen Handelsinvest har opdateret prospektet og CI-dokumenter for alle afdelinger.
CI-dokumenterne er opdateret med omkostningstal for 2020. For prospektet er der sket
opdateringer/?ndringer:

Opdateret prospekt

2021-02-23T11:35:56Z

Investeringsforeningen IA Invest har offentliggjort opdateret prospekt for foreningen.

New base prospectus for covered bonds, mortgage bonds and bonds issued pursuant to Section 15 of the Danish Mortage-Credit Loans and Mortgage-Credit Bonds etc. Act

2021-02-23T09:46:01Z

To Nasdaq Copenhagen A/S?????????????????????????????????????????????????????????????????????????????????????????? 23 February 2021
???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? Announcement no. 23 /2021

New base prospectus for covered bonds, mortgage bonds and bonds issued pursuant to Section 15 of the Danish Mortage-Credit Loans and Mortgage-Credit Bonds etc. Act

Offentligg?relse af nyt basisprospekt for S?rligt D?kkede Obligationer, Realkreditobligationer og obligationer i medf?r af �� 15 i lov om realkreditl?n og realkreditobligationer

2021-02-23T09:46:01Z

Til Nasdaq Copenhagen A/S?????????????????????????????????????????????????????????????????????????????????????? 23. februar 2021
???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? Meddelelse nr. 23/2021

Offentligg?relse af nyt basisprospekt for S?rligt D?kkede Obligationer, Realkreditobligationer og obligationer i medf?r af �� 15 i lov om realkreditl?n og realkreditobligationer

Correction: Opening of new fixed-rate bond

2021-02-22T14:30:55Z

This republication is made due a wrong categorisation, which is now correct. At 14.48 CET the correct publication was sent.

Correction: ?bning af ny fastforrentet obligation

2021-02-22T14:30:55Z

Denne genpublisering skyldes en forkert kategorisering, som nu er korrekt. Klokken 14.48 blev den korrekte publikation sendt.

Investeringsforeningen Jyske Invest har ajourf?rt prospekt

2021-02-22T13:23:38Z

Prospektet for Investeringsforeningen Jyske Invest er opdateret.

Opening of new fixed-rate bond

2021-02-22T12:57:38Z

Realkredit Danmark will open a new callable fixed-rate mortgage covered bond (SDRO) with the following characteristics:

?bning af ny fastforrentet obligation

2021-02-22T12:57:38Z

Realkredit Danmark A/S ?bner ny fastforrentet, konverterbar, s?rligt d?kket realkreditobligation (SDRO).

Offentligg?relse af prospekter, Linde & Partners, Investeringsforeningen Wealth Invest

2021-02-19T14:09:27Z

Hermed offentligg?res opdaterede prospekter for afdeling Linde & Partners Global Value Fond og afdeling Linde & Partners Dividende Fond i Investeringsforeningen Wealth Invest.?

ClearPoint Neuro Announces Pricing of?Public Offering of 1,850,140 Shares of Common Stock

2021-02-19T03:10:47Z

IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the ��Company��), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today the pricing of its underwritten public offering of 1,850,140 shares of its common stock at a price to the public of $23.50 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 277,520 shares of its common stock at the public offering price less underwriting discounts and commissions. All the shares are being offered by the Company. The offering is expected to close on February 23, 2021, subject to customary closing conditions.

Diffusion Pharmaceuticals Announces Full Exercise of Underwriter��s Option to Purchase Additional Shares of Common Stock

2021-02-18T21:05:00Z

CHARLOTTESVILLE, Va., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN)?(��Diffusion�� or the ��Company��), an innovative biopharmaceutical company developing novel therapies to deliver oxygen to areas of the body where it is needed most, announced today that the underwriter of its previously announced underwritten public offering has exercised in full its option to purchase an additional 4,390,244 shares of its common stock at a price to the public of $1.025 per share, less underwriting discounts and commissions. After giving effect to the option closing, the aggregate gross proceeds to Diffusion from the offering were approximately $34.5 million, before deducting underwriting discounts and commissions and offering expenses payable by Diffusion.

SiTime Corporation Announces Pricing of?Follow-on Public Offering

2021-02-18T04:20:00Z

SANTA CLARA, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- SiTime Corporation (Nasdaq: SITM), a leader in MEMS timing, today announced the pricing of its follow-on public offering of 3,000,000 shares of its common stock at a price to the public of?$127.00?per share, including 1,500,000 shares of common stock to be sold by MegaChips Corporation and 1,500,000 shares of common stock to be issued and sold by SiTime. SiTime will not receive any proceeds from the sale of shares of common stock by MegaChips Corporation. The gross proceeds of the offering to SiTime, before deducting underwriting discounts and commissions and other offering expenses, are expected to be $190.5 million, excluding any exercise of the underwriters�� option. The offering is expected to close on?February 22, 2021, subject to customary closing conditions.

Y-mAbs Announces Pricing of Public Offering of Common Stock

2021-02-18T00:14:48Z

NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the ��Company�� or ��Y-mAbs��) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced the pricing of its public offering of 2,439,025 shares of its common stock at a public offering price of $41.00 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $100.0 million. All of the shares are being offered by Y-mAbs. In addition, Y-mAbs has granted the underwriters a 30-day option to purchase up to an additional 365,853 shares of common stock at the public offering price, less the underwriting discounts. The offering is expected to close on?February 22, 2021, subject to the satisfaction of customary closing conditions.